Search results
Signs and Symptoms of Multiple Myeloma
Health via Yahoo News· 1 month agoMedically reviewed by Marla Anderson, MD Multiple myeloma is a rare blood cancer that affects your plasma cells. It makes up about 1.8% of all new cancer...
A 41-year-old woman's life-threatening blood cancer was misdiagnosed as carpal tunnel because of her...
INSIDER via Yahoo News· 1 year agoRoban Lampkin, a former lingerie football league player, was diagnosed with multiple myeloma in...
Woman’s blood cancer misdiagnosed as carpal tunnel due to burning hand pain
The Independent via Yahoo News· 1 year agoA 41-year-old woman was diagnosed with carpal tunnel after experiencing symptoms of burning hand...
Regeneron (REGN) Posts Positive Data on Blood Cancer Candidate
Zacks via Yahoo Finance· 5 months agoRegeneron Pharmaceuticals, Inc. REGN announced positive results from the phase I/II study on its...
Biotech Stock Roundup: MRNA Up on Vaccine Data, BMY's Updates & More News
Zacks via Yahoo Finance· 2 weeks agoIt was a regular week in the biotech sector with a focus on pipeline and regulatory updates. While...
Regeneron (REGN) Posts Upbeat Data From Multiple Myeloma Study
Zacks via Yahoo Finance· 11 months agoA mid-stage study data shows that treatment with Regeneron's (REGN) experimental antibody achieved a...
20 Countries with the Highest Cancer Survival Rates in the World
Insider Monkey via Yahoo Finance· 1 week agoIn this article, we will be taking a look at the 20 countries with the highest cancer survival rates...
Bristol Myers (BMY) Posts Data From Multiple Myeloma Study
Zacks via Yahoo Finance· 2 years agoBristol Myers (BMY) and partner, 2seventy bio, report top-line data from a late-stage study...
2seventy Bio Shares Jump On Positive Data From Bristol Myers-Partnered Cancer Immunotherapy
Benzinga via Yahoo Finance· 2 years agoBristol Myers Squibb Co (NYSE: BMY) and 2seventy bio Inc (NASDAQ: TSVT) have announced topline...
Legend (LEGN) Up 4% on sNDA Submission for Carvykti Expanded Use
Zacks via Yahoo Finance· 11 months agoLegend (LEGN) announces regulatory submission for expanded use of Carvykti to include adult patients...
